WHO naming stem · suffix · 24 listed names
-rubicin
This page was written with AI.
antineoplastics, daunorubicin derivatives
Where it sits in a name
WHO writes the stem as -rubicin. So the letters rubicin sit at the end of the name (…rubicin).
All 24 names WHO lists under -rubicin
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 5 of 24 names appear in these lists: 5 in the US list (FDA Drugs@FDA) and 2 in the EU central list (EMA); 4 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- aclarubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- aldoxorubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amrubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- berubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- camsirubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- carubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- daunorubicin
- detorubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- doxorubicinUS brands: DOXIL (LIPOSOMAL), ADRIAMYCIN PFS (discontinued in FDA listings), RUBEX (discontinued in FDA listings)EU (central) brands: Caelyx pegylated liposomal, Myocet liposomal, Zolsketil pegylated liposomal, Celdoxome pegylated liposomal (lapsed)
- epirubicinUS brands: ELLENCEEU (central) brands: none found
- esorubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- galarubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- idarubicinEU (central) brands: none found
- ladirubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- leurubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- medorubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nemorubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pidorubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pirarubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rodorubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sabarubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- valrubicinUS brands: VALSTAR PRESERVATIVE FREEEU (central) brands: none found
- zoptarelin doxorubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zorubicinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Decode another name
Decoded
amrubicin
Listed INNCarries the WHO stem -rubicin
- -rubicinend of the nameWHO lists it hereWHO definition: antineoplastics, daunorubicin derivatives
“amrubicin” is an INN that WHO lists under -rubicin in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -rubicin (Part II B) and the 24 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.